Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Clearside Biomedical, Inc. (CLSD) had Weighted-Average Shares Outstanding (Diluted) of 76.92M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$2.33M |
|
$-8.22M |
|
$0.25M |
|
$2.08M |
|
$7.54M |
|
$-5.21M |
|
$-2.30M |
|
$-7.51M |
|
$-7.51M |
|
$-8.22M |
|
$-8.22M |
|
$-8.22M |
|
$-8.22M |
|
$-5.21M |
|
$-5.12M |
|
76.92M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
76.92M |
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$15.96M |
|
$3.15M |
|
$3.70M |
|
$19.67M |
|
$5.01M |
|
-- |
|
$60.57M |
|
$65.58M |
|
$-45.91M |
|
$-45.91M |
|
$-45.91M |
|
77.27M |
|
| Cash Flow Statement Financials | |
$-5.83M |
|
$-0.01M |
|
$-0.55M |
|
$20.02M |
|
$13.63M |
|
$-6.39M |
|
$0.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
89.36% |
|
-223.39% |
|
-223.39% |
|
-- |
|
-322.23% |
|
-352.92% |
|
$-5.84M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
1.51 |
|
59.41 |
|
17.91% |
|
17.91% |
|
-41.81% |
|
17.91% |
|
$-0.59 |
|
$-0.08 |
|
$-0.08 |
|